T1 Biomarker 339 354 long-envisioned
T2 Condition 33 40  humans
T3 Level 82 89 T cells
T4 Level 1701 1728 neoantigen-specific T cells
T5 Condition 1443 1451 patients
T6 Gene 737 747  molecules
T7 Condition 965 971 tumour
T8 Condition 1138 1144 tumour
T9 Condition 580 587 tumours
T10 Condition 1004 1010 tumour
T11 Level 1203 1210 T cells
T13 Condition 1646 1652 tumour
T14 Condition 102 108 cancer
T15 Condition 580 586 tumour
T16 Condition 1283 1291 patients
T18 Gene 708 732 human leukocyte antigen 
T19 Condition 906 927 T-cell specificities 
T20 Protein 255 269 normal tissues
T21 Condition 930 936 cancer
T22 Condition 15 21 tumour
T23 Protein 1348 1366 wild-type antigens
T24 Level 1313 1320 T cells
T25 CL 1583 1603 anti-programmed cell
T26 Condition 929 945  cancer patients
T27 Condition 168 174 tumour
T29 Condition 168 193 tumour-specific mutations
T30 Condition 1417 1423 tumour
T31 Intervention 295 301 thymic
T32 CL 848 866 T-cell populations
T33 Condition 563 572 mutations
T34 Condition 386 392 tumour
T35 Gene 1572 1581 anti-PD-1
